COST COMPARISON OF ABATACEPT AND ADALIMUMAB BASED ON AMPLE, A 2-YEAR HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Gaultney, J. [1 ]
Budd, D. [2 ]
Nappi, C. [3 ]
Benucci, M. [4 ]
Iannazzo, S. [5 ]
Alemao, E. [6 ]
Sabater, J. [7 ]
机构：
[1] Mapi Grp, Houten, Netherlands
[2] Bristol Myers Squibb, Paris, France
[3] Bristol Myers Squibb, Rome, Italy
[4] Osped S Giovanni di Dio Firenze, Florence, Italy
[5] SIHS Hlth Econ Consulting, Turin, Italy
[6] Bristol Myers Squibb, Princeton, NJ USA
[7] Bristol Myers Squibb, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.2368
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0348
引用
收藏
页码：551 / 552
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ABATACEPT COMPARED TO ADALIMUMAB IN ITALY BASED ON A HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS
    Gaultney, J.
    Nappi, C.
    Benucci, M.
    Iannazzo, S.
    Sion, K.
    Alemao, E.
    Sabater, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A644 - A644
  • [2] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
    Weinblatt, Michael E.
    Schiff, Michael H.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael A.
    Fleischmann, Roy
    [J]. RHEUMATOLOGY, 2014, 53 : 88 - 88
  • [3] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
    Schiff, Michael
    Weinblatt, Michael E.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael
    Fleischmann, Roy
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 86 - 94
  • [4] Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
    Fleischmann, Roy
    Weinblatt, Michael E.
    Schiff, Michael
    Khanna, Dinesh
    Maldonado, Michael A.
    Nadkarni, Anagha
    Furst, Daniel E.
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (07) : 907 - 913
  • [5] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VS ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: KEY EFFICACY AND SAFETY RESULTS FROM THE AMPLE TRIAL
    Weinblatt, Michael E.
    Schiff, Michael H.
    Fleischmann, Roy
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael A.
    [J]. RHEUMATOLOGY, 2013, 52 : 45 - 46
  • [6] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: TWO YEAR RESULTS FROM THE AMPLE STUDY
    Schiff, M.
    Weinblatt, M.
    Valente, R.
    van der Heijde, D.
    Citera, G.
    Elegbe, A.
    Maldonado, M.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 64 - 64
  • [7] Head-to-head trial shows abatacept is as effective as adalimumab in patients with active rheumatoid arthritis
    Mayor, Susan
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (08) : 431 - 431
  • [8] Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
    Smolen, Josef S.
    Burmester, Gerd-Ruediger
    Combe, Bernard
    Curtis, Jeffrey R.
    Hall, Stephen
    Haraoui, Boulos
    van Vollenhoven, Ronald
    Cioffi, Christopher
    Ecoffet, Cecile
    Gervitz, Leon
    Ionescu, Lucian
    Peterson, Luke
    Fleischmann, Roy
    [J]. LANCET, 2016, 388 (10061): : 2763 - 2774
  • [9] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
    Weinblatt, Michael E.
    Schiff, Michael
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 28 - 38
  • [10] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Maldonado, Michael
    Weinblatt, Michael
    Schiff, Michael
    Fleischmann, Roy
    Valente, Robert
    Van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
12345